Read + Share
Amedeo Smart
Independent Medical Education
Oksuz S, Kinikoglu O, Sariyar N, Ozdemir M, et al. Prognostic value of PSA Kinetic Ratio in high-volume mCSPC patients treated with abiraterone or enzalutamide: a single-center retrospective study. BMC Cancer 2026;26:728.PMID: 41987096
Email
LinkedIn
Privacy Policy